GMRS
Unloved QualityAI neutralGMR Solutions Inc. · Healthcare · United States · $580M cap · $11.0M/day traded
$11.30 -3.9% · close 12 Nov · scored 13 Nov
Unloved Quality: Strong and cheap, but the market has not warmed to it.
Results expected 16 Nov. Analysts cut next year's EPS estimate 0.6% over 13 weeks.
As of 13 Nov 2026, the MoatMap Score for GMR Solutions Inc. (GMRS) is 73/100, ranked against 25,000+ stocks in 38 markets (Quality 60, Value 71, Momentum 38, each scored against its sector).
Does the score work? Each tenth of the ranking, tracked monthly. See the record →
GMR Solutions has reaffirmed full-year 2026 guidance and is repaying $200 million of debt after repricing its term loan, which reduces financial risk. Against that, insiders sold 4.36% of the shares over the past 90 days, a large amount that needs explaining, and the company still carries meaningful leverage in a higher-rate environment.
ABOUT GMR SOLUTIONS INC.
Read
GMR Solutions Inc. is a specialized healthcare services provider focused on operating and managing outpatient medical care facilities and diagnostic clinics. The company utilizes advanced medical technologies and streamlined patient workflows to deliver high-quality, cost-effective diagnostic and treatment services. Its competitive position is supported by strategic partnerships with regional healthcare networks and a focus on high-demand suburban markets.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.4B | 6.0B | 5.7B | 3.1% | 5.9B | 6.0B | 6.4B | 5.4% |
| EPS | -0.91 | -0.32 | 0.16 | — | -2.03 | 1.62 | 1.81 | 235.8% |
| Shares | — | 54.0M | 54.0M | 0.0% | 54.0M | — | — | — |
| Debt | — | 4.9B | 5.4B | 10.5% | 4.8B | — | — | — |
| Equity | — | 188.0M | 204.2M | 8.6% | — | — | — | — |
| Op CF | 257.8M | 246.2M | 641.1M | 57.7% | 639.8M | — | — | — |
| Inv CF | -143.0M | 48.0M | -250.0M | — | — | — | — | — |
| Fin CF | -142.2M | -59.2M | -135.8M | — | — | — | — | — |
Not enough steady price history for a read yet.
How this is worked out
The Price check reads only the chart, the price side of the Momentum score in words; it is not the MoatMap Score.
- Still falling: It set a new 52-week low in the last two weeks, after a deep fall.
- Finding a floor: It fell hard, but has set no new low for more than two weeks.
- Turning up: It has climbed off its low and is back above a rising 50-day average.
- In an uptrend: It is near its 52-week high and above its 200-day average.
- No clear trend: None of the above: no recent deep fall and no steady climb.
- No read yet (this stock): Not enough price history yet: it needs a year of trading.
In past US falls, waiting for Turning up cut the chance of another 20% drop from 42% to 33%. Returns were no better, and 33% of turns failed.
The exact rules
Still falling is a new 52-week low in the last two weeks, at least 25% below the high, with the low set after the high. Finding a floor is the same fall with no new low in the last two weeks. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average, with the 50-day average above the 200-day, and within 15% of the high. No clear trend is everything else. No read yet is under 252 trading days of history, or missing data. A new state shows once it has held for three trading days.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn (the Turning up rule above) cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of GMRS are excluded.
| Ticker | Company | Mkt Cap | Score |
|---|---|---|---|
| GMRS | GMR Solutions Inc.(you) | $580M | 73 |
| CYH | Community Health Systems, Inc. | $412M | 63 |
| INNV | InnovAge Holding Corp. | $1.3B | 77 |
| USPH | U.S. Physical Therapy, Inc. | $1.3B | 65 |
| WW | WW International, Inc. | $135M | 72 |
| ASTH | Astrana Health, Inc. | $1.9B | 65 |
| SGRY | Surgery Partners, Inc. | $2.1B | 64 |
| SRTA | Strata Critical Medical, Inc. | $412M | 45 |
| NHC | National HealthCare Corporation | $3.7B | 73 |
| PNTG | The Pennant Group, Inc. | $1.5B | 54 |
Peer medians: ROE -31.0% · P/E 25.9x · Gross margin 63.3%
Company Deep Dive
A 10,000-word report: the business and its segments, what management promised on earnings calls and whether it delivered, the competition, and how things could turn out.